Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
Condition: Haemophilus Influenzae Type B Infection Interventions: Drug: Vaxelis; Drug: PedvaxHIB Sponsors: Johns Hopkins Bloomberg School of Public Health; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Haemophilus Influenzae (Hib) | India Health | Influenza Vaccine | Research | Study | Vaccines